Victory Capital Management Inc Cyclerion Therapeutics, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
$2.37 - $7.14 $8,908 - $26,839
-3,759 Closed
0 $0
Q1 2020

May 04, 2020
SELL
$2.46 - $5.84 $1,525 - $3,620
-620 Reduced 14.16%
3,759 $10,000
Q4 2019

Feb 04, 2020
BUY
$1.8 - $13.43 $3,175 - $23,690
1,764 Added 67.46%
4,379 $14,000
Q3 2019

Nov 12, 2019
BUY
$8.12 - $14.54 $21,233 - $38,022
2,615 New
2,615 $32,000

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0
View Full List

About Cyclerion Therapeutics, Inc.

CYCN Quotes by TradingView
  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $201M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email